Clinical Trials Logo

Clinical Trial Summary

Computers allow individuals to engage in economic, social, and entertainment activities. Despite the many benefits of computer use, many individuals with rheumatic diseases may have difficulty using a computer. However, currently there is almost no information on the problems individuals with rheumatic diseases experience using a computer. Baseline information on the types of problems experienced by individuals with rheumatic diseases as well as the magnitude of those problems is needed before methods can be developed to intervene and remediate them. In this study we will develop and administer to a representative sample of patients with rheumatic diseases a survey which will examine the type and magnitude of computer problems experienced by those with rheumatic diseases. The goal of this study is to complete a needs assessment on the problems experienced by those with rheumatic diseases during computer use. This assessment will lay the groundwork for the development of outcome measures and interventions to improve computer use for individuals with rheumatic diseases. In the future it will assist individuals with rheumatic diseases to be able to use computers more comfortably and efficiently.


Clinical Trial Description

Computers allow individuals to engage in economic, social, and entertainment activities. They are vital for full participation in many areas of society, and have become a necessity for many types of employment, particularly management and administrative positions. Despite the many benefits of computer use, many individuals with rheumatic diseases such as rheumatoid arthritis (RA), osteoarthritis (OA), and fibromyalgia (FM) may be unable to use a computer due to limitations in hand function or sitting ability. These limitations can prevent the physical manipulation of computer peripherals or inhibit the ability to sit for extended periods of time at a computer. Despite the importance of computer use there is almost no information on the problems individuals with rheumatic diseases experience using a computer. Baseline information on the types of problems experienced by individuals with rheumatic diseases as well as the magnitude of those problems is needed before methods can be developed to intervene and remediate them. The aim of this study is to complete a needs assessment on the problems experienced by those with rheumatic diseases during computer use. This assessment will lay the groundwork for the development of outcome measures and interventions to improve computer use for individuals with rheumatic diseases by identifying problem areas and examine the magnitude of those problems. This study will be implemented in two phases. In Phase I (months 01-05) we will use several focus group sessions of 5-10 participants to acquire consumer input to develop and refine a survey to examine the problems experienced during computer use by people with rheumatic diseases. In Phase II the survey developed in Phase I {Computer Problem Survey (ComPS)] will be administered to a representative sample of patients with rheumatic diseases (n = ~1500) to ascertain the type and magnitude of computer problems (months 06-12). These 2 phases will be used to answer the following questions: 1. What aspects of computer use are reported to be a problem for individuals with RA, OA, and FM? 2. What is the magnitude of these problems for individuals with RA, OA, and FM? 3. How does the magnitude differ when examined by age, gender, education, race/ethnicity, and work status? At the end of the study we will have gathered the descriptive data necessary to 1) begin modifying current computer performance evaluations to focus on measuring computer use performance in individuals with rheumatic diseases; and 2) develop and test interventions, such as adaptive equipment and ergonomics, to promote continued computer use for individuals with difficulties using a computer due to physical limitations. ;


Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT00177320
Study type Observational
Source University of Pittsburgh
Contact
Status Completed
Phase N/A
Start date March 2005
Completion date May 2005

See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4